0001753926-20-000209.txt : 20200728
0001753926-20-000209.hdr.sgml : 20200728
20200728081158
ACCESSION NUMBER: 0001753926-20-000209
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200728
DATE AS OF CHANGE: 20200728
EFFECTIVENESS DATE: 20200728
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aspargo Laboratories, Inc.
CENTRAL INDEX KEY: 0001805092
IRS NUMBER: 843757833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-361806
FILM NUMBER: 201051809
BUSINESS ADDRESS:
STREET 1: 550 SYLVAN AVENUE, SUITE 102
CITY: ENGLEWOOD CLIFFS
STATE: NJ
ZIP: 07632
BUSINESS PHONE: 201-408-4831
MAIL ADDRESS:
STREET 1: 550 SYLVAN AVENUE, SUITE 102
CITY: ENGLEWOOD CLIFFS
STATE: NJ
ZIP: 07632
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001805092
Aspargo Laboratories, Inc.
550 SYLVAN AVENUE, SUITE 102
ENGLEWOOD CLIFFS
NJ
NEW JERSEY
07632
201-408-4831
DELAWARE
VirgaTech, Inc.
None
Corporation
true
2019
Michael
Demurjian
61 Hubbard Avenue
Red Bank
NJ
NEW JERSEY
07701
Executive Officer
Director
Promoter
Founder of the Company.
Michael
Rice
155 Walnut St.
Englewood
NJ
NEW JERSEY
07631
Director
Fred
Biehl
75 Eisenhower Parkway
Roseland
NJ
NEW JERSEY
07068
Director
Pharmaceuticals
No Revenues
- 06b
true
0001753926-20-000030
2020-02-05
false
true
false
5000
David Sukoff
4232120
Arq Advisors LLC
289499
57 DEFOREST AVE, SUITE A
SUMMIT
NJ
NEW JERSEY
07901
CA
CALIFORNIA
CO
COLORADO
FL
FLORIDA
MD
MARYLAND
MA
MASSACHUSETTS
NH
NEW HAMPSHIRE
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
PA
PENNSYLVANIA
SC
SOUTH CAROLINA
VT
VERMONT
WV
WEST VIRGINIA
false
8500000
2511900
5988100
false
88
700
true
0
Sales commissions amount reflects amount due as of filing date of this Amendment for recently engaged placement agent. Estimated future commissions is contingent on sales volume.
0
The Company is virtual. All executive officers and directors serve without compensation.
false
Aspargo Laboratories, Inc.
/s/ Michael Demurjian
Michael Demurjian
Chairman and CEO
2020-07-28